PRILZESO
LIVE

Serial Number

79408099

Owner

ENZENE BIOSCIENCES LIMITED

Attorney

Blake M. Murray

Filing Date

Jul 13, 2024

Add to watchlist:

No watchlists yet
View on USPTO

PRILZESO Trademark

Serial Number: 79408099 • Registration: 7877207

PRILZESO is a trademark filed by ENZENE BIOSCIENCES LIMITED on July 13, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

ENZENE BIOSCIENCES LIMITED (4 trademarks)

Plot No. A 22, A/1/2 Chakan Industrial Area,

Entity Type: 99

Trademark Details

Filing Date

July 13, 2024

Registration Date

August 5, 2025

Published for Opposition

June 17, 2025

Goods & Services

Amino acid preparations for medical purposes; amino acid preparations for medical use; biotechnological diagnostic preparations for medical use; calcium supplements; pharmaceutical preparations being hormone preparations for human use; injectable pharmaceuticals for treatment of anaphylactic reactions; medicines for human purposes; parathyroid hormone preparations; pharmaceutical compositions in the nature of stem cells for medical use; Cardiovascular pharmaceutical preparations; pharmaceutical preparations for the treatment of cardiovascular conditions; pharmaceutical preparations for medical purposes, particularly, for treating cardiovascular diseases; pharmaceutical preparations for the treatment of disorders of the endocrine system; pharmaceutical preparations for the treatment of diseases of the endocrine system; pharmaceutical preparations for treating rheumatologic diseases; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for human use, particularly, for treating cardiovascular diseases; pharmaceutical preparations and substances being pharmaceuticals for treating endocrine conditions; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations for the treatment of bone fractures; pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical preparations for the treatment of musculo-skeletal disorders; pharmaceutical preparations for the treatment of diseases of the musculo-skeletal system; thyroid and parathyroid hormone preparations

Medical tubing for administering drugs; automatic vaccination apparatus; injectors for medical purposes being auto injectors for the administration of pharmaceutical preparations; medical and veterinary apparatus and instruments, particularly, for monitoring blood oxygen saturation, blood gas concentrations, and vital signs; medical apparatus and instruments, particularly, for monitoring blood oxygen saturation, blood gas concentrations, and vital signs; medical apparatus for introducing pharmaceutical preparations into the human body, particularly, medical fluid injectors; medical syringes; medication fluid injectors; syringes for medical use; syringes for injections; syringes for medical purposes

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 16, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 30, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 29, 2026 OPNR
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 5, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 15, 2026 FICS
FINAL DISPOSITION PROCESSED
Feb 15, 2026 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 5, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 5, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 5, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 17, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jun 17, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 11, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 18, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 14, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 14, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 14, 2025 TROA
REFUSAL PROCESSED BY IB
Nov 30, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 14, 2024 RFCS
REFUSAL PROCESSED BY MPU
Nov 14, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 11, 2024 RFCR
NON-FINAL ACTION WRITTEN
Nov 10, 2024 CNRT
ASSIGNED TO EXAMINER
Nov 9, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 4, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 4, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 31, 2024 REPR